Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine
Abstract Background Tardive dyskinesia (TD) is a movement disorder related to long‐term antipsychotic use and characterized by involuntary repetitive movements that often affect the oral and facial muscles. Although valbenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor, is an effective...
Saved in:
| Main Authors: | Yuhei Mori, Yuhei Suzuki, Akiko Sato, Risa Shishido, Yuri Kobayashi, Yuta Fukuchi, Shota Inada, Yuka Iwasaki, Riko Sato, Keitaro Takada, Naoki Morita, Itaru Miura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | PCN Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/pcn5.70135 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of valbenazine in the treatment of cervical dystonia: a pilot study
by: Salma Aziz, et al.
Published: (2025-05-01) -
Valbenazine for the Treatment of Adults with Tardive Dyskinesia
by: Harshit Gupta, et al.
Published: (2021-06-01) -
Treatment of tardive dyskinesia caused by long-term antipsychotic use: case reports and literature review
by: I. Pabarčiūtė, et al.
Published: (2020-12-01) -
Possibilities of group chronophysiotherapy at gall-bladder dyskinesias
by: O. A. Poddubnaya, et al.
Published: (2012-02-01) -
Adverse effects of electroconvulsive therapy on cognitive performance
by: Sasha S. Getty, et al.
Published: (2017-10-01)